• HealthHack
  • Posts
  • 🧠 The HealthTech That Treats You Like a Person, Not a Chart

🧠 The HealthTech That Treats You Like a Person, Not a Chart

Smarter care tools for chronic conditions, early detection, and everyday dignity

Author

HealthHack
September 05, 2025

Hi there 👋 

This week, we’re focusing on innovations that matter most to people living with long-term health conditions.

Whether you're managing diabetes, navigating cancer recovery, or simply hoping healthcare gets a little more human, this edition of the HealthHack Newsletter offers real-world solutions designed to ease burdens, improve outcomes, and give time back to patients and providers alike.

Let’s get into it.

🗳 Poll of the Week

Would you feel comfortable switching from insulin pens to a wearable insulin pump?

Login or Subscribe to participate in polls.

EDITOR’S CHOICE ✨ 

Insulin Precision with Every Patch

ViCentra’s Kaleido 2 insulin pump is what happens when medical tech takes user experience seriously.

The patch pump is ultra-light, color-customizable, and designed to feel more like a smart device than a medical burden. With closed-loop integration and CGM compatibility, it’s a sleek answer to clunky diabetes care - and a potential game-changer for everyday insulin users.

Chronic Care, Reimagined

Your Health, Your Way

MyWay Digital Health isn’t just a diabetes dashboard. It’s a personalised, AI-enabled platform that connects with NHS systems to deliver real-time education and insights to patients and clinicians. The goal? Empowering people to manage their conditions before they spiral. Early results show higher engagement and better outcomes.

🔗 Read more

Reclaiming Time for Care

Healthcare professionals lose hours every day to administrative tasks. Aiomics wants to give that time back. Its AI-powered documentation platform captures speech, handwriting, and paperwork in one streamlined flow, then translates it into structured, coded, and audit-secure data for existing systems. The result? Fewer errors, faster reimbursements, and more time for human care.

🔗 Read more

Cancer, Clarified

Strong Recovery for Breast Cancer Patients

Tensive’s REGENERA implant is built to address a silent crisis in post-lumpectomy care: 1.6 million women each year go without reconstruction. Their bioresorbable scaffold supports natural tissue regrowth, avoids imaging issues, and fits seamlessly into surgery workflows. Early trial results suggest better aesthetics, high satisfaction, and no interference with radiation.

🔗 Read more

Diagnosing Danger Earlier

Cyted Health is tackling esophageal cancer - one of the deadliest cancers globally - with a minimally invasive, molecular diagnostic platform. Used across the UK and now entering the US, Cyted's tech combines cell collection with advanced biomarker testing, aiming to catch disease early while it’s still treatable.

🔗 Read more

VISIONARY VOICES 💬 

A Call for Digital Unity

Fragmented evaluation frameworks are choking the potential of Europe’s most promising health innovations. A coalition of EU innovators is now calling for a unified, pragmatic framework starting in 2026 - one that supports safe, effective solutions without needless delay.

Without alignment, even the best medical devices - like those improving chronic care, cancer screening, or diabetes management - struggle to reach patients across borders. The message is clear: scale or stagnate.

AI in Action

The Cancer-Resistant Drug

CHARM Therapeutics is taking on the Achilles heel of first-gen menin inhibitors: resistance mutations. Using its DragonFold AI platform, CHARM is designing next-gen molecules that retain potency even when the cancer mutates. For patients with treatment-resistant acute myeloid leukemia, this could mean longer-lasting therapies and fewer setbacks.

🔗 Read more

Clarity Before the Crisis

ArcaScience is using AI to improve one of the least understood aspects of drug development: benefit-risk evaluation. Its 24-model engine parses 100 billion health data points to forecast safety and efficacy long before trials fail. This could help pharma teams course-correct earlier and give patients more tailored, data-backed treatment options from the start.

🔗 Read more

Digital Infrastructure

When Two Become One

SeqOne is building the operating system for clinical genomics. By acquiring UK-based Congenica, the company will offer an integrated AI-powered platform serving 160+ labs across 30+ countries. Faster interpretations, deeper insights, and more actionable results could be a win for patients with rare diseases and cancers alike.

🔗 Read more

Powering the Microbiome Movement

MRM Health is betting big on microbial therapeutics. Its CORAL platform uses rationally selected bacterial strains to create potent consortia that tackle inflammatory diseases. With positive early data in ulcerative colitis and new programs targeting immune-oncology, this approach might just reshape how we treat chronic inflammation.

🔗 Read more

Well that’s it! 🚀 

From more flexible insulin delivery to smarter cancer diagnostics and gentler recovery tools, this issue highlights the technologies quietly changing lives - especially for older adults managing chronic or complex health conditions.

The future of care is becoming more tailored, intuitive, and humane.

Thanks for reading the HealthHack Newsletter - we’ll see you next week with more breakthroughs that put real people first.

Your HealthHack Team